Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 5 von 37

Details

Autor(en) / Beteiligte
Titel
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments
Ist Teil von
  • The World Allergy Organization journal, 2021-10, Vol.14 (10), p.100592-100592, Article 100592
Ort / Verlag
Milwaukee: Elsevier Inc
Erscheinungsjahr
2021
Quelle
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
Beschreibungen/Notizen
  • In the recent years, it was recognized that type-2 inflammation links many forms of nasal polyposis with severe asthma. Thus, some biological drugs developed for severe asthma appeared to exert an effect on nasal polyposis. So far, there are several trials supporting this concept; therefore, some monoclonal antibodies for severe asthma were assessed also in polyposis, with promising results. Since different specialists are involved in the management of nasal polyposis (eg, pulmonologists, ENT, allergists), it was felt that an educational and informative document was needed to better identify the indications of biologicals in nasal polyposis. We collected the main Italian Scientific Societies, and prepared (under the Allergic Rhinitis and its Impact on Asthma, ARIA) a document endorsed by all Societies, to provide a provisional statement for the future use of monoclonal antibodies as a medical treatment for polyposis. It is the first nationwide endorsed document on this aspect. The current pathogenic knowledge and the experimental evidence are herein reviewed, and some suggestions for a correct prescription and follow-up are provided.
Sprache
Englisch
Identifikatoren
ISSN: 1939-4551
eISSN: 1939-4551
DOI: 10.1016/j.waojou.2021.100592
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_4ccea6e57c304ff7bb0926fa46f35dac

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX